Dec 5, 2018, 05:48 AM by Michael Croft

EDINBURGH, UK - Dec 5, 2018 - Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, developed by Synpromics, in a new preclinical research target

Dec 4, 2018, 01:02 AM by Michael Croft

LONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Starting from the year of 2013, BOC Sciences has been providing a wide variety of metabolites and impurities for scientists in the research community

Dec 4, 2018, 00:58 AM by Michael Croft

LONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Earlier this October, Creative Peptides, one of the world’s leading peptide manufacturers, has announced a series of peptide modification services

Dec 3, 2018, 11:27 AM by Michael Croft

CHAPEL HILL, NC, UNITED STATES - Dec 3, 2018 - TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBD

Nov 30, 2018, 11:22 AM by Michael Croft

MIT Technology Review | Even as a furious debate broke out in China over gene-edited babies, some scientists in the US are also hoping to improve tomorrow's children.

Nov 30, 2018, 11:17 AM by Michael Croft

BAR HARBOR, ME, UNITED STATES - Nov 30, 2018 - Vicki P. Losick, Ph.D., has been named the inaugural recipient of an award from the William Procter Scientific Innovation Fund

Nov 30, 2018, 09:45 AM by Michael Croft

KING OF PRUSSIA, PA, UNITED STATES - Nov 27, 2018 - Greenphire, the global leader in financial technology for clinical trials, announced today that it has been ranked as 391 on Deloitte's 2018 Technology Fast 500™

Nov 30, 2018, 01:59 AM by Michael Croft

SHIRLEY, NY - Nov 30, 2018 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the launch of its microRNA expression profiling  microarray services, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivity

Nov 28, 2018, 12:30 PM by Michael Croft

NPR.org | He Jiankui, who shocked the world by asserting he had genetically edited twin girls, faced growing criticism from other researchers as he spoke at a scientific conference in Hong Kong.

Nov 28, 2018, 11:35 AM by Michael Croft

Nov 28, 2018, 11:14 AM by Michael Croft

PRINCETON, NJ - Nov 28, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2

Nov 27, 2018, 14:45 PM by Michael Croft

TORONTO, ON, CANADA - Nov 27, 2018 - Data volumes everywhere are growing rapidly. In genomics — the study of the entirety of genetic information of individuals and populations— new sequencing technologies and techniques are turning this flood into a torrent, and all of that new data holds the promise of delivering new insights into biology, health, and disease

Nov 27, 2018, 09:09 AM by Michael Croft

MIAMI, FL, UNITED STATES - Nov 27, 2018 - The U.S. Food and Drug Administration  (FDA) has selected Booz Allen Hamilton to support development, modernization, and enhancement of the FDA Adverse Event Reporting System (FAERS)

Nov 27, 2018, 05:06 AM by Michael Croft

CAMBRIDGE, UK - Nov 27, 2018 - Prostate cancer is the most common cancer in men, with 1 in 8 diagnosed at some point in their lives

Nov 27, 2018, 04:38 AM by Michael Croft

BOSTON, MA - Nov 27, 2018 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today announced the latest release of its Unified Data Model (UDM) file format, v5

Nov 26, 2018, 12:52 PM by Michael Croft

NOIDA, INDIA - Nov 26, 2018 - HCL Technologies (HCL), a leading global technology company, today announced that it has been recognized as a Leader in Everest Group’s Life Sciences Digital Services North America PEAK Matrix™

Nov 26, 2018, 11:34 AM by Michael Croft

TEDDINGTON, UNITED KINGDOM - Nov 26, 2018 - Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories

Nov 26, 2018, 08:14 AM by Michael Croft

STAT | A researcher's claim that he used genome editing to alter DNA of human embryos, resulting in the birth a few weeks ago of twin girls, stunned scientists.

Nov 24, 2018, 01:59 AM by Michael Croft

SHIRLEY, NY - Nov 24, 2018 - Shirley, NY, Nov 24th, 2018, Creative Biolabs, as one of excellent suppliers and manufacturers in antibody production field, announced that the anti-membrane protein antibody1 has been developed successfully by using the phage display technology, which plays very crucial role in a majority of life science researches

Nov 21, 2018, 13:26 PM by Michael Croft

CHAPEL HILL, NC, UNITED STATES - Nov 20, 2018 - TARGET PharmaSolutions, Inc., a company focused on real world evidence, is pleased to announce that it has entered into a strategic partnership with Gilead Sciences for TARGET-NASH and TARGET-HBV